ES2107832T3 - Una composicion farmaceutica para la administracion intranasal de hidroxocobalamina. - Google Patents
Una composicion farmaceutica para la administracion intranasal de hidroxocobalamina.Info
- Publication number
- ES2107832T3 ES2107832T3 ES94918322T ES94918322T ES2107832T3 ES 2107832 T3 ES2107832 T3 ES 2107832T3 ES 94918322 T ES94918322 T ES 94918322T ES 94918322 T ES94918322 T ES 94918322T ES 2107832 T3 ES2107832 T3 ES 2107832T3
- Authority
- ES
- Spain
- Prior art keywords
- pct
- hydroxocobalamine
- pharmaceutical composition
- intranasal administration
- date jun
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Abstract
LA INVENCION SE REFIERE A UNA FORMULACION FARMACEUTICA, EN UNA COMPOSICION Y FORMA ADECUADAS PARA LA ADMINISTRACION NASAL, QUE CONTIENE HIDROXOCOBALAMINA DISUELTA EN UNA CONCENTRACION SUPERIOR A 1% (W/W), CON UNA VISCOSIDAD INFERIOR A 1000 CP.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE9301418A BE1007839A6 (nl) | 1993-12-20 | 1993-12-20 | Farmaceutische compositie voor de nasale toediening van hydroxocobalamine. |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2107832T3 true ES2107832T3 (es) | 1997-12-01 |
Family
ID=3887657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94918322T Expired - Lifetime ES2107832T3 (es) | 1993-12-20 | 1994-05-13 | Una composicion farmaceutica para la administracion intranasal de hidroxocobalamina. |
Country Status (11)
Country | Link |
---|---|
US (1) | US5801161A (es) |
EP (1) | EP0735859B1 (es) |
JP (1) | JP3623962B2 (es) |
AT (1) | ATE156014T1 (es) |
AU (1) | AU6969994A (es) |
BE (1) | BE1007839A6 (es) |
DE (1) | DE69404675T2 (es) |
DK (1) | DK0735859T3 (es) |
ES (1) | ES2107832T3 (es) |
GR (1) | GR3025014T3 (es) |
WO (1) | WO1995017164A1 (es) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6187790B1 (en) | 1999-03-04 | 2001-02-13 | Neal R. Cutler | Use of cilostazol for treatment of sexual dysfunction |
US6132757A (en) | 1998-05-01 | 2000-10-17 | Neal R. Cutler | Treatment of sexual dysfunction in certain patient groups |
US6426084B1 (en) * | 2000-06-19 | 2002-07-30 | Neal R. Cutler | Treatment of sexual dysfunction in certain patient groups |
WO2000038696A1 (en) * | 1998-12-28 | 2000-07-06 | Allergy Limited, Llc | Cyanocobalamin (vitamin b12) treatment in allergic disease |
US6562838B2 (en) * | 2001-01-26 | 2003-05-13 | R. T. Alamo Ventures I, L.L.C. | Treatment of cardiovascular disease with quinolinone enantiomers |
US6458804B1 (en) | 2001-01-26 | 2002-10-01 | R.T. Alamo Venturesi, Llc | Methods for the treatment of central nervous system disorders in certain patient groups |
US6451813B1 (en) | 2001-01-26 | 2002-09-17 | R. T. Alamo Ventures I, Llc | Treatment of gastroparesis in certain patient groups |
US20030096748A1 (en) * | 2001-06-04 | 2003-05-22 | The Regents Of The University Of Michigan | Methods and compositions for the treatment of diseases associated with signal transduction aberrations |
US7041677B2 (en) * | 2002-03-01 | 2006-05-09 | R.T. Alamo Ventures I, Llc | Use of monochloroflosequinan in the treatment of sexual dysfunction |
US7208628B2 (en) * | 2002-05-13 | 2007-04-24 | Kansas State University Research Foundation | Compositions and methods for the treatment of hepatitis C virus infection |
US7074893B2 (en) * | 2002-06-03 | 2006-07-11 | Regents Of The University Of Michigan | Methods and compositions for the treatment of diseases associated with signal transduction aberrations |
US7404489B1 (en) | 2003-03-04 | 2008-07-29 | Qol Medical, Llc | Cyanocobalamin low viscosity aqueous formulations for intranasal delivery |
US7229636B1 (en) | 2003-03-04 | 2007-06-12 | Nastech Pharmaceutical Company Inc. | Cyanocobalamin low viscosity aqueous formulations for intranasal delivery |
US20050032740A1 (en) * | 2003-08-06 | 2005-02-10 | Balaji Venkataraman | Vitamin compositions for the treatment and prevention of vascular disease and dementia |
US20050032741A1 (en) * | 2003-08-06 | 2005-02-10 | Balaji Venkataraman | Vitamin Compositions |
US20050089558A1 (en) * | 2003-10-28 | 2005-04-28 | Alamo Pharmaceuticals, Llc | Compositions and methods for the co-formulation and administration of tramadol and propoxyphene |
US20050153946A1 (en) * | 2003-12-24 | 2005-07-14 | Collegium Pharmaceuticals, Inc. | Temperature-stable formulations, and methods of development thereof |
CA2623215A1 (en) * | 2004-09-23 | 2006-12-28 | The Regents Of The University Of California | Assay for vitamin b12 absorption and method of making labeled vitamin b12 |
JP2009504767A (ja) | 2005-08-17 | 2009-02-05 | フレミング・アンド・カンパニー・ファーマシューティカルズ | ビタミンb12鼻用スプレーおよび使用方法 |
JP5769924B2 (ja) * | 2006-06-23 | 2015-08-26 | パル ファーマシューティカル, インコーポレーテッド | 鼻内送達用シアノコバラミン低粘度水性製剤 |
AU2014202415B2 (en) * | 2006-06-23 | 2016-02-18 | Par Pharmaceutical, Inc | Cyanocobalamin low viscosity aqueous formulations for intranasal delivery |
CN101011409B (zh) * | 2007-02-06 | 2010-08-11 | 浙江爱生药业有限公司 | 一种维生素b12滴鼻液组合物 |
DK2632430T3 (en) * | 2010-10-29 | 2018-09-17 | Troikaa Pharmaceuticals Ltd | : NASAL COMPOSITIONS OF B12 VITAMIN |
US9585908B1 (en) | 2010-11-08 | 2017-03-07 | Chromaceutical Advanced Technologies, Inc. | Collyrium composition and method of using same |
NL2010550C2 (en) | 2012-11-30 | 2014-06-04 | Klaas Alouis Riepma | An intranasal pharmaceutical composition containing vitamin b12. |
JP5797227B2 (ja) * | 2013-05-21 | 2015-10-21 | パル ファーマシューティカル, インコーポレーテッド | 鼻内送達用シアノコバラミン低粘度水性製剤 |
JP6897971B2 (ja) | 2015-05-15 | 2021-07-07 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 関節炎を処置するための、方法および組成物 |
NL2015506B1 (en) | 2015-09-25 | 2017-04-20 | Alouis Riepma Klaas | Oral administration of Vitamin B12 dispersed in a hydrophobic continuous phase |
US10723718B2 (en) | 2017-11-07 | 2020-07-28 | The Regents Of The University Of Michigan | Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use |
GB202013645D0 (en) * | 2020-08-31 | 2020-10-14 | Innotesto Bvba | Pharmacetical compositions for the nasal administration of a colbalamin compound |
JP7038448B1 (ja) * | 2021-07-19 | 2022-03-18 | 雅行 沼田 | 抗アレルギー用投与デバイス |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE788780A (fr) * | 1971-09-21 | 1973-01-02 | Rolland Sa A | Procede pour le diagnostic de l'hypercyanurie |
US4724231A (en) * | 1985-04-16 | 1988-02-09 | Nastech Pharmaceutical, Inc. | Nasel compositions containing vitamin B12 |
DE3682862D1 (de) * | 1985-04-16 | 1992-01-23 | Nastech Pharm Co | Aerosolmittel zur nasenverstaeubung von vitamin b 12. |
-
1993
- 1993-12-20 BE BE9301418A patent/BE1007839A6/nl not_active IP Right Cessation
-
1994
- 1994-05-13 WO PCT/EP1994/001567 patent/WO1995017164A1/en active IP Right Grant
- 1994-05-13 JP JP51711695A patent/JP3623962B2/ja not_active Expired - Fee Related
- 1994-05-13 DK DK94918322.2T patent/DK0735859T3/da active
- 1994-05-13 AU AU69699/94A patent/AU6969994A/en not_active Abandoned
- 1994-05-13 ES ES94918322T patent/ES2107832T3/es not_active Expired - Lifetime
- 1994-05-13 DE DE69404675T patent/DE69404675T2/de not_active Expired - Lifetime
- 1994-05-13 US US08/663,240 patent/US5801161A/en not_active Expired - Lifetime
- 1994-05-13 AT AT94918322T patent/ATE156014T1/de not_active IP Right Cessation
- 1994-05-13 EP EP94918322A patent/EP0735859B1/en not_active Expired - Lifetime
-
1997
- 1997-10-14 GR GR970402659T patent/GR3025014T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP3623962B2 (ja) | 2005-02-23 |
US5801161A (en) | 1998-09-01 |
EP0735859A1 (en) | 1996-10-09 |
DE69404675D1 (de) | 1997-09-04 |
GR3025014T3 (en) | 1998-01-30 |
JPH09507477A (ja) | 1997-07-29 |
BE1007839A6 (nl) | 1995-10-31 |
DE69404675T2 (de) | 1997-11-27 |
AU6969994A (en) | 1995-07-10 |
EP0735859B1 (en) | 1997-07-30 |
DK0735859T3 (da) | 1998-03-09 |
WO1995017164A1 (en) | 1995-06-29 |
ATE156014T1 (de) | 1997-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2107832T3 (es) | Una composicion farmaceutica para la administracion intranasal de hidroxocobalamina. | |
ATE195249T1 (de) | Pharmazeutische aerosol welche mindestens ein zucker enthält | |
FI960102A (fi) | Uusi farmaseuttinen seos | |
NO971889L (no) | Forbindelser og sammensetninger for levering av aktive midler | |
PT703786E (pt) | Utilizacao de nonapeptideos e decapeptideos para a preparacao de um medicamento para o tratamento da sida | |
EG20540A (en) | New emulsion formulation | |
AU685075B2 (en) | Pharmaceutical composition for treating nicotine dependence | |
FI964332A (fi) | Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen | |
BR9910329A (pt) | Composto, composição farmacêutica, processo para estimular a liberação do hormÈnio de crescimento da pituitária de um mamìfero, e, uso de um composto | |
FI972434A0 (fi) | Lamotrigiiniä sisältävä farmaseuttinen koostumus | |
BR9814498A (pt) | Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica | |
ATE290858T1 (de) | N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin | |
AU1191795A (en) | Deuterated active substances in transdermal application | |
BR9508021A (pt) | Composição farmacêutica para o tratamento de distúrbios esquizofrênicos, uso de um agente imunossupressor, e, processo de tratamento de um paciente esquizofrênico | |
PT742716E (pt) | Composicao farmaceutica para administracao transdermica sistemica contendo a substancia activa morfina-6-glucuronido | |
NO963143L (no) | Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne | |
DK0817643T3 (da) | Forbindelser og præparater til administration af aktive midler | |
IL117734A0 (en) | Beta-carbolines and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 19951201 Kind code of ref document: R Effective date: 19951201 |
|
FG2A | Definitive protection |
Ref document number: 735859 Country of ref document: ES |
|
FA2A | Application withdrawn |
Effective date: 19980804 |